Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute of Allergy and Infectious Diseases (NIAID) |
---|---|
Information provided by: | National Institute of Allergy and Infectious Diseases (NIAID) |
ClinicalTrials.gov Identifier: | NCT00001137 |
The purpose of this study is to determine what combinations of anti-HIV drugs work best in patients treated over several years. The study will also assess the occurrence of side effects and opportunistic infections in patients with low viral loads compared to those with higher viral loads.
Condition |
---|
HIV Infections |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Adult AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) Protocol |
Estimated Enrollment: | 4500 |
Study Start Date: | January 2000 |
A compilation of outcomes of various antiretroviral therapies would be beneficial when evaluating which strategies are most effective in long-term treatment of HIV-1. Using data from present and recently completed studies, this study will collect information on therapies and their control of HIV infection and maintenance of durable suppression of HIV-1 replication.
No treatment is provided by this study, but patients will continue to receive highly active antiretroviral therapy (HAART) from other studies in which they are coenrolled. Blood and urine collection will occur at study entry and periodically throughout the study. Women may undergo pelvic exams and Pap smears. Portions of blood samples will be stored to evaluate genotypic/phenotypic susceptibility testing. Medical histories, physical exams, and questionnaires will be completed periodically.
Ages Eligible for Study: | 13 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Participants in this study will be HIV infected men and women who are enrolled in an ACTG parent study and are receiving HAART.
Inclusion Criteria
Exclusion Criteria
Study Chair: | Constance A. Benson, MD | Division of Infectious Disease, Antiviral Research Center, University of California, San Diego |
Study Chair: | Ann C. Collier, MD | University of Washington, Harborview Medical Center |
Responsible Party: | DAIDS ( Rona Siskind ) |
Study ID Numbers: | ACTG A5001, AACTG A5001 |
Study First Received: | January 28, 2000 |
Last Updated: | December 24, 2008 |
ClinicalTrials.gov Identifier: | NCT00001137 |
Health Authority: | United States: Federal Government |
Treatment Experienced Treatment Naive Virus Replication AIDS-Related Opportunistic Infections HIV-1 Risk Factors Incidence |
RNA, Viral Anti-HIV Agents Viral Load Lipodystrophy Nervous System Cardiovascular System |
Virus Diseases Opportunistic Infections Sexually Transmitted Diseases, Viral HIV Infections Sexually Transmitted Diseases |
Lipodystrophy Acquired Immunodeficiency Syndrome AIDS-Related Opportunistic Infections Retroviridae Infections Immunologic Deficiency Syndromes |
RNA Virus Infections Slow Virus Diseases Immune System Diseases Lentivirus Infections Infection |